HBM Healthcare Investments AG (CH001262) | Finanzwire

Basculer en Français

8306	Companies
115328	Keywords
55598	Articles
62613	Press releases

Headlines Articles Press releases HBM Healthcare Investments AG

Home
Companies
HBM Healthcare Investments AG

PRESS RELEASE

published on 01/22/2024 at 06:45, 10 months ago

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year
HBM Healthcare Investments AG has released their Quarterly Report for the first nine months of the 2023/2024 financial year, revealing a loss of CHF 87 million for the quarter ending on December 31, 2023. The report also details the impact of unfavourable currency developments and market indices on the company's performance, as well as the developments in the portfolio of public and private companies. The outlook section discusses recent industry developments and hints at a potentially brighter market environment with persisting volatility. The full report is available on the company's website.

HBM Healthcare Investments Quarterly Report Financial Year Currency Developments Market Environment
PRESS RELEASE

published on 11/02/2023 at 17:46, 1 year ago

Key Figures 31.10.2023
PRESS RELEASE

published on 10/16/2023 at 17:47, 1 year 1 month ago

Key Figures 15.10.2023
PRESS RELEASE

published on 10/16/2023 at 06:40, 1 year 1 month ago

HBM Healthcare Investments activates share buyback programme
PRESS RELEASE

published on 10/16/2023 at 06:30, 1 year 1 month ago

HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year
PRESS RELEASE

published on 10/02/2023 at 17:47, 1 year 1 month ago

Key Figures 30.09.2023
PRESS RELEASE

published on 10/02/2023 at 17:46, 1 year 1 month ago

HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023
PRESS RELEASE

published on 09/18/2023 at 17:47, 1 year 2 months ago

Key Figures 15.09.2023
PRESS RELEASE

published on 09/01/2023 at 17:47, 1 year 2 months ago

Key Figures 31.08.2023
PRESS RELEASE

published on 08/16/2023 at 17:46, 1 year 3 months ago

Key Figures 15.08.2023

Accesswire

Published on 11/22/2024 at 16:00, 1 hour 33 minutes ago

Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 38 minutes ago

Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 18 minutes ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 2 hours 48 minutes ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 3 minutes ago

Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 16:55, 37 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 hour 33 minutes ago

Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 33 minutes ago

AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 2 hours 6 minutes ago

EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 2 hours 46 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company

Les Echos

Published on 11/22/2024 at 14:35, 2 hours 58 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 10 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 22 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 23 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 23 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE